Rexam to Build Aluminum Beverage Can Plants in Russia and Brazil

Rexam, the global consumer packaging company and the world's leading beverage can maker, announces that it is to build its second beverage can making plant in Russia as well as a new can end making plant in Brazil.

Russia

The new plant in Russia is in Chelyabinsk in the Urals. Customers have already made important can filling investments in the Central and Eastern area of Russia which has a population of more than 60 million people. Customers are expected to invest further to meet the significant and growing consumption which today is being satisfied by filled cans supplied from outside the Urals.

The greenfield aluminium can plant will consist of one production line with an annual capacity of 800 million cans and will be able to swing between 33cl and 50cl can manufacture. It is due to come on stream in early 2008 and represents an investment of some US$73m (£39m) mainly in 2007.

Brazil

The new plant in Brazil is an end making facility which, along with the current end plant in Recife, will be used to satisfy Rexam's can end needs in Brazil and other countries. The plant will be located in Manaus in the Amazonas state in the north of Brazil. Due to come on line at the start of 2007, it represents an investment of around US$33m (£18m) in the remainder of 2006 and early 2007.

Commenting, Lars Emilson, Rexam's Chief Executive, said: "These are both significant investments to capture growth. Taken together with the recent investment in the new plant for Red Bull, the acquisition in Egypt and further conversion of lines to new sizes, they demonstrate that we are firmly committed to growing alongside our customers and consolidating our leadership position in the global beverage can industry."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.